title: Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
authors.forename: C
authors.initials: C
authors.lastname: Schmid
authors.forename: M
authors.initials: M
authors.lastname: Schleuning
authors.forename: J
authors.initials: J
authors.lastname: Aschan
authors.forename: O
authors.initials: O
authors.lastname: Ringdén
authors.forename: J
authors.initials: J
authors.lastname: Hahn
authors.forename: E
authors.initials: E
authors.lastname: Holler
authors.forename: U
authors.initials: U
authors.lastname: Hegenbart
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: M
authors.initials: M
authors.lastname: Dugas
authors.forename: G
authors.initials: G
authors.lastname: Ledderose
authors.forename: H-J
authors.initials: HJ
authors.lastname: Kolb
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006801:Humans; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D016019:Survival Analysis; D014184:Transplantation, Homologous
chemical_list: D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor